Eli Lilly and Company: Fibromyalgia trials

The registry lists 12 Fibromyalgia studies with Eli Lilly and Company as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 3 7Phase 4 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)CompletedNCT01621191Phase 3Results posted
• A Study of Duloxetine in FibromyalgiaCompletedNCT01552057Phase 3Results posted
• A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia SyndromeCompletedNCT01237587Phase 3Results posted
• A Study for Adult Patients With FibromyalgiaCompletedNCT00965081Phase 4Results posted
• Fibromyalgia Health Outcome Study on Cost of TreatmentsCompletedNCT00725101Results posted
• A Study Comparing Duloxetine and Placebo in the Treatment of FibromyalgiaCompletedNCT00673452Phase 4Results posted
• A Study for Adolescents With Fibromyalgia SyndromeWithdrawnNCT01089621Phase 4
• Duloxetine Versus Placebo for FibromyalgiaCompletedNCT00489073Phase 3
• Duloxetine Versus Placebo in the Treatment of FMSCompletedNCT00233025Phase 3
• Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia SyndromeCompletedNCT00190866Phase 3
• A Study of Duloxetine in the Treatment of FibromyalgiaCompletedNCT00125892Phase 3
• Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical TrialApproved for marketingNCT00071708